Attached files

file filename
EXCEL - IDEA: XBRL DOCUMENT - AMERICAN CRYOSTEM CorpFinancial_Report.xls
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

AMENDMENT NO. 1 TO

FORM 10-Q
 
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended June 30, 2011

Commission file number: 333-164909
 
AMERICAN CRYOSTEM CORPORATION
(Name of registrant as specified in its charter)
     
Nevada
 
26-4574088
(State or other jurisdiction of incorporation or organization)
 
(I.R.S. Employer Identification No.)
 
188 E. Bergen Pl., Suite 204, Red Bank, NJ 07701
(Address of principal executive offices)(Zip Code)
 
(732) 747-1007
(Registrant’s telephone number, including area code)
 
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
Yes x No o
 
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).
Yes o No x
 
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.
 
Large accelerated filer o
Accelerated filer o
Non-accelerated filer o
(Do not check if smaller reporting company)
Smaller reporting company x
 
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act)
Yes o  No x
 
As of August 8, 2011, there were 26,111,862 shares of common stock issued and outstanding.
 
 
 

 
 
EXPLANATORY NOTE

The sole purpose of this Amendment No. 1 to American CryoStem Corporation’s Quarterly Report on Form 10-Q (the “Form 10-Q”) for the period ended June 30, 2011, as filed with the Securities and Exchange Commission on August 15, 2011, is to furnish Exhibit 101 to the Form 10-Q in accordance with Rule 405 of Regulation S-T. Exhibit 101 provides the financial statements and related notes from the Form 10-Q formatted in XBRL (eXtensible Business Reporting Language).

No other changes have been made to the Form 10-Q. This Amendment No. 1 to the Form 10-Q does not reflect events that may have occurred subsequent to the original filing date, and does not modify or update in any way disclosures made in the original Form 10-Q.
 
PART II - OTHER INFORMATION
 
ITEM 6.
EXHIBITS AND 8K
   
Exhibit No.
Description
 
 
(a)
Documents furnished as exhibits hereto:
   
Exhibit No.
Description
101.INS
XBRL Instance Document
101.SCH
XBRL Taxonomy Extension Schema Document
101.CAL
XBRL Taxonomy Calculation Linkbase Document
101.DEF
XBRL Taxonomy Extension Definition Linkbase Document
101.LAB
XBRL Taxonomy Label Linkbase Document
101.PRE
XBRL Taxonomy Presentation Linkbase Document

 
 

 
 
SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 
AMERICAN CRYOSTEM CORPORATION
     
 September 8, 2011
By:
/s/ John Arnone
 
 
John Arnone, Chief Executive Officer
 
 
(Principal Executive Officer)
 
 
 
 September 8, 2011
By:
/s/ Anthony Dudzinski
 
 
Anthony Dudzinski, Treasurer
 
 
(Principal Financial Officer)